iTeos Therapeutics, Inc.: accounts_payable
| Value | {"amount": 9603000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-09-30) |
| Status | current |
| Entity | iTeos Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:13:05.345676+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/21cfb52a-8fdd-4565-a5b4-7a9802873242
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-22-024473Retrieved: 2026-08-19T18:13:05.345676+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001808865/accounts-payable/2022-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/21cfb52a-8fdd-4565-a5b4-7a9802873242
History
- no predecessors — first report